Please assess the completion status of the following clinical trial:

Trial Title: MiDAS I (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic Lumbar Spinal Stenosis (LSS) primarily caused by dorsal element hypertrophy.~* Prior failure of conservative therapy.~* Radiologic evidence of LSS (L3-L5), Ligamentum flavum \> 2.5mm, confirmed by pre-op MRI and/or CT.~* Central canal cross sectional area ≤ 100 square mm.~* Anterior listhesis ≤ 5.0mm.~* Able to walk at least 10 feet unaided before being limited by pain.~* Available to complete 12 weeks of follow-up.~* Consistent with the intended labeling statement for use.~* Able to use all package components to perform the procedure.~* A signed Informed Consent Form is obtained from the patient.~Exclusion Criteria:~* Prior surgery at intended treatment level.~* History of recent spinal fractures with concurrent pain symptoms.~* Disabling back or leg pain from causes other than LSS (e.g. acute compression fracture, metabolic neuropathy, or vascular claudication symptoms, etc.).~* Significant / symptomatic disk protrusion or osteophyte formation.~* Excessive / symptomatic facet hypertrophy.~* Bleeding disorders and/or current use of anti-coagulants.~* Use of acetylsalicylic acid (ASA) and/or non-steroidal anti-inflammatory drug (NSAID) within 5 days of treatment.~* Epidural steroids within prior three weeks.~* Inability of the patient to lie prone for any reason with anesthesia support (e.g. chronic obstructive pulmonary disease (COPD), obesity, etc.).~* Any potential wound healing pathologies that may compromise outcomes, including diabetes, excessive smoking history, cancer, connective tissue diseases, recent spine radiation and severe COPD.~* Dementia and/or inability to give informed consent.~* Pregnancy.~* Intended treatment that is defined by the product labeling contraindications.~* On Workman's Compensation or considering litigation associated with back pain.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- interlaminar decompression (Type: OTHER): Commercially available product (mild® Device Kit) used to perform interlaminar decompression

Based on this trial design, predict the completion outcome and termination type (if applicable).